Implementation of Plate Imaging for Demonstration of Monoclonality in Biologics Manufacturing Development

Reference

1. 1.↵
   (1997) ICH Harmonised Tripartite Guidline Derivation and Characterisation of Cell Substrates Used for Production of Biotechnological/Biological Prodcuts Q5D Version 11–13.
2. 2.↵
   World Health, O. (2013) WHO Expert Committee on Biological Standardization. World Health Organ Tech Rep Ser, 1–366, back cover.
3. 3.↵
   1. Kennett S.

   (2014) Establishing Clonal Cell Lines – A Regulatory Perspective Black Cell, Blue Cell, Old Cell, New Cell? WCBP.
4. 4.↵
   1. Novak R.

   (2017) Regulatory Perspective on the Evaluation of Clonality of Mammalian Cell Banks. CASSS CMC Forum 2017.
5. 5.↵
   1. Welch J.

   (2017) Tilting at Clones: A Regulatory Perspective on the Importance of “Clonality” of Mammalian Cell Banks. Cell Line Development and Engineering Europe.
6. 6.↵
   1. DeMaria C. T.,
   2. Cairns V.,
   3. Schwarz C.,
   4. Zhang J.,
   5. Guerin M.,
   6. Zuena E.,
   7. Estes S.,
   8. Karey K. P.

   (2007) Accelerated clone selection for recombinant CHO cells using a FACS-based high-throughput screen. Biotechnol Progr 23, 465–472.

   OpenUrlPubMed
7. 7.↵
   1. Misaghi S.,
   2. Shaw D.,
   3. Louie S.,
   4. Nava A.,
   5. Simmons L.,
   6. Snedecor B.,
   7. Poon C.,
   8. Paw J. S.,
   9. Gilmour-Appling L.,
   10. Cupp J. E.

   (2016) Slashing the timelines: Opting to generate high-titer clonal lines faster via viability-based single cell sorting. Biotechnol Prog 32, 198–207.

   OpenUrl
8. 8.↵
   1. Sleiman R. J.,
   2. Gray P. P.,
   3. McCall M. N.,
   4. Codamo J.,
   5. Sunstrom N. A.

   (2008) Accelerated cell line development using two-color fluorescence activated cell sorting to select highly expressing antibody-producing clones. Biotechnol Bioeng 99, 578–587.

   OpenUrlCrossRefPubMedWeb of Science
9. 9.↵
   1. Fieder J.,
   2. Schulz P.,
   3. Gorr I.,
   4. Bradl H.,
   5. Wenger T.

   (2017) A single-step FACS sorting strategy in conjunction with fluorescent vital dye imaging efficiently assures clonality of biopharmaceutical production cell lines. Biotechnol J 12.
10. 10.↵
    1. Coller H. A.,
    2. Coller B. S.

    (1986) Poisson Statistical-Analysis of Repetitive Subcloning by the Limiting Dilution Technique as a Way of Assessing Hybridoma Monoclonality. Method Enzymol 121, 412–417.

    OpenUrlPubMed
11. 11.↵
    1. Lietzke R.,
    2. Unsicker K.

    (1985) A statistical approach to determine monoclonality after limiting cell plating of a hybridoma clone. J Immunol Methods 76, 223–228.

    OpenUrlPubMed
12. 12.↵
    1. Shaw D.,
    2. Yim M.,
    3. Tsukuda J.,
    4. Joly J. C.,
    5. Lin A.,
    6. Snedecor B.,
    7. Laird M. W.,
    8. Lang S. E.

    (2017) Development and characterization of an automated imaging workflow to generate clonally-derived cell lines for therapeutic proteins. Biotechnol Prog.
13. 13.↵
    1. Frye C.,
    2. Deshpande R.,
    3. Estes S.,
    4. Francissen K.,
    5. Joly J.,
    6. Lubiniecki A.,
    7. Munro T.,
    8. Russell R.,
    9. Wang T.,
    10. Anderson K.

    (2016) Industry view on the relative importance of “clonality” of biopharmaceutical-producing cell lines. Biologicals 44, 117–122.

    OpenUrl
14. 14.↵
    1. Wurm M.,
    2. Wurm M. J.

    (2017) Cloning of CHO Cells, Productivity and Genetic Stability—A Discussion. Processes 5, 13.

    OpenUrlCrossRef